Search
Close this search box.

Female pattern baldness

Female pattern hair loss, akin to male pattern baldness but distinct in manifestation, arises from a complex interplay of genetic, hormonal, and environmental factors. This condition, known as androgenetic alopecia in women, leads to a noticeable thinning of hair across the scalp, particularly in the crown area, while typically preserving the frontal hairline.

Diagnosis of female pattern baldness hinges on identifying the characteristic pattern of hair thinning, often most pronounced when the hair is parted, sometimes revealing a “Christmas tree” pattern. This nuanced understanding of female hair loss paves the way for targeted treatments.

QR678® Neo emerges as a groundbreaking therapy in this context, specifically addressing the unique aspects of female pattern hair loss. Unlike conventional treatments that may offer generic solutions, QR678® Neo targets the underlying causes of androgenetic alopecia by rejuvenating hair follicles and promoting hair density and strength.

The therapy’s efficacy lies in its ability to deliver a proprietary blend of growth factors and peptides directly to the affected scalp areas, thereby stimulating hair regrowth and halting further hair loss. These bio-mimetic molecules naturally emulate the growth factors found in a healthy scalp, ensuring a treatment that is both effective and aligned with the body’s natural processes.

For women experiencing the distress of hair thinning and loss, QR678® Neo offers a clinically proven solution that not only addresses the cosmetic concerns but also tackles the psychological impact of androgenetic alopecia. By restoring hair health and appearance, QR678® Neo provides women with a renewed sense of confidence and well-being, making it a preferred choice for those seeking a definitive response to female pattern baldness.

Some of the factors causing Female Pattern Baldness are:

Hormones

Female pattern baldness is caused by elevated levels of dihydrotestosterone (DHT) hormone. Dihydrotestosterone is a metabolic product of the conversion of free testosterone by 5-alpha reductase. DHT causes the progressive shrinkage of hair follicles which may eventually lead to their becoming dormant.

Ageing

Due to changes in hormonal levels as a person ages, onset of baldness with age may also take place. Aging causes a progressive decrease in the Anagen hair (growth phase of hair cycle) and leads to an increased number of dormant hair follicles.

Genetics

Baldness is dependent on several genetic factors. It is strongly associated with the AR gene on the X chromosome. About 80% of the cases of Androgenetic Alopecia are due to genetic factors.

PCOS And Oral Contraceptives

PCOS or Poly-Cystic Ovarian Syndrome is a condition of hormonal imbalance that may be associated with elevated levels of androgens leading to hair loss from the frontal or parietal areas of the scalp.

Female pattern baldness, a widespread yet challenging condition to treat, has historically left both patients and doctors seeking more effective solutions. The traditional treatment landscape has included options like:

A vasodilator that improves blood flow to the follicles, supporting hair growth but requiring ongoing application.
Targets hormonal causes of hair loss but may have systemic side effects.
Utilizes growth factors from the patient's own blood to stimulate follicle health, with varying results.
A cutting-edge approach that uses regenerative cells to enhance follicle growth factors, still in experimental stages for widespread clinical use.

Against this backdrop, QR678® Neo emerges as a superior alternative, offering distinct advantages

QR678® Neo stands out in the North American market as a groundbreaking solution for female pattern baldness, providing a reliable, effective, and patient-friendly option for those seeking to overcome the challenges of hair loss.

The QR678® Neo therapy in Androgenetic Alopecia:

The QR678® Neo therapy is a proprietary, first in class hair fall & hair regrowth therapy, which has revolutionized the treatment of hair fall in alopecia. This formulation was invented in India & has been named QR678 inspired by the new generation ubiquitous presence of “Quick Response“ QR code. 678 in Morse Code signifies “there is no answer”. This formulation has been named QR678® to signify a “Quick Response to a disease which earlier had no answer”.

Female Pattern Baldness , Hair Loss Fall Treatment for

Before & After Results

Get Started with QR 678 neo

FAQ's

QR678® Neo consists of a proprietary blend of natural growth factors, identical to those found in a healthy scalp, ensuring its safety for universal application. This precise formulation contains targeted concentrations of specific factors known to promote hair growth. With QR678® Neo, patients experience no side effects. The treatment is administered on an outpatient basis, with visible results emerging as early as eight weeks after commencement. Hear directly from our patients about their experiences with the QR678® Neo hair loss treatment.

QR678® Neo treatments involve 5 to 10 sessions, spaced approximately 2-3 weeks apart. Visible improvements can be observed within a few weeks following the commencement of the therapy. Once optimal results are attained, further injections are unnecessary unless hair loss recurs. This enduring effect is due to QR678® Neo’s capacity to rejuvenate hair follicles. Discover the reasons behind QR678® Neo’s high efficacy in reducing hair loss and enhancing hair regrowth.

QR678® Neo offers a safe treatment experience without any side effects, enabling you to continue with your day-to-day activities right after each session. It is recommended to use a mild shampoo at least a day post-treatment and refrain from scratching or rubbing the area treated. If any concerns arise, consult your treatment provider for guidance.

  • Utilizing QR678® Neo in conjunction with hair transplant procedures has been shown to yield highly successful outcomes. QR678® Neo enhances hair density more rapidly and mitigates the shedding (catagen loss) of newly transplanted hair. The growth factors present in QR678® Neo contribute to quicker healing and reactivation of dormant hair follicles, thereby:
  • Enhancing the survival rate of hair follicles. Accelerating the tissue healing and repair process Revitalizing inactive hair follicles and promoting hair regrowth. Boosting the health of existing hair, making it fuller and stronger. QR678® Neo treatments can be administered in several sessions, starting three to four weeks post a successful hair transplant surgery. Additionally, QR678® Neo can be applied prior to hair transplant surgery to minimize the area needing transplantation and further improve the surgical outcomes.

Genetic hair loss, often hereditary and observed in both men and women, can indeed be managed effectively if treatment commences early. This type of hair loss, which frequently runs in families, typically follows a distinctive pattern: an M or W shape in men and thinning along the hair part in women. If you have a family history of patterned baldness, it’s crucial to monitor your hair health closely and consult a doctor at the first sign of hair loss.

There are several well-established treatments for genetic hair loss, including:

  • Topical and Oral Medications: Minoxidil, applied topically, and Finasteride, taken orally, are commonly prescribed to combat hair loss.
  • Hair Transplantation: Surgical options such as Follicular Unit Transplantation (FUT) and Follicular Unit Extraction (FUE) are effective methods for restoring hair.
  • Nutritional Supplements: Physicians may recommend hair growth supplements. Key nutrients like Vitamins A, C, and Biotin, along with minerals such as zinc and iron, are known to support hair health and reduce loss attributed to genetic factors.

Alopecia following chemotherapy is a widespread and emotionally impactful side effect of cancer treatments. The fear of hair loss often deters patients from undergoing necessary therapies. While hair loss from chemotherapy is usually temporary, regrowth can take months or even up to a year. However, recent advancements in treatment can expedite recovery:

  • Scalp Cooling: An FDA-approved method, particularly for breast cancer patients, scalp cooling can reduce chemotherapy’s impact on hair. It works by narrowing blood vessels in the scalp, lessening the amount of chemotherapy drugs reaching the hair follicles. The process involves a cooling unit that circulates coolant on the scalp, initiated about 30 minutes before chemotherapy begins. Side effects may include mild discomfort, nausea, and dry skin.
  • Topical Minoxidil: This medication enhances blood flow to the hair follicles, helping to prevent their shrinkage and encouraging hair retention.
  • QR678® Neo Hair Regrowth Treatment: FDA-approved and safe, QR678® Neo is effective in treating chemotherapy-induced alopecia in both men and women without side effects or discomfort. Clinical trials have demonstrated its efficacy, with results that can last a lifetime.

These treatments offer hope and options for those facing hair loss due to chemotherapy, providing a path to recovery and helping to mitigate one of the most challenging aspects of cancer treatment.